Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1105 - 1112 of 12065 results

EnforceMintz — Tech Corner: Q&A with Mintz’s E-Discovery Pro Regarding Artificial Intelligence
February 8, 2024| Blog| Viewpoint

EnforceMintz — Government Scrutiny of Medicare Advantage Organizations Expected to Continue in 2024
February 8, 2024| Blog| Viewpoint

EnforceMintz — COVID-19 Fraud Enforcement Unlikely to Slow Down in 2024
February 8, 2024| Blog| Viewpoint

ESG Political Partisanship: Guidance for In House Counsel
February 7, 2024| Podcast| Viewpoint

“What is Love? Baby, Don’t Sue Me: AB 1076 and California’s Quickly Approaching Valentine’s Day Notification Deadline”
February 7, 2024| Blog| Viewpoint

Finance 101: How to Fix Canada's Broken Universities
February 7, 2024| News

Mintz Venture Watch — Volume 6: A Report on Deal Trends from 2023
February 6, 2024| Article| Viewpoint

IRS Opens Registration Portal for the Elective Payment or Transfer of Tax Credits
February 6, 2024| Alert| Viewpoint
News & Press Releases
Mintz Advises PHLUR on Acquisition by TSG Consumer
July 29, 2025
Mintz advised PHLUR, a modern fragrance brand recognized for its emotion-led storytelling and accessible positioning, in its acquisition by TSG Consumer, a leading private equity firm specializing in consumer brands.
Mintz Attorneys Named to Los Angeles Business Journal’s 2025 “Leaders of Influence: Litigators & Trial Attorneys” List
July 28, 2025
Mintz Member Esteban Moralesand Special Counsel Nada Shamonki has been recognized by Los Angeles Business Journal in its 2025 “Leaders of Influence: Litigators & Trial Attorneys” list which recognizes lawyers who “go to the proverbial mat to fight for their clients,” according to the publication.
Is Biopharma M&A In a Holding Pattern or a ‘New Normal’
July 23, 2025
Life Sciences International Chair Cheryl Reicin recently joined the Scrip M&A Podcast to share insights on the evolving landscape of biopharmaceutical mergers and acquisitions. In the episode, Cheryl highlights an uptick in pre-M&A activity, as major pharmaceutical companies increasingly leverage license and option agreements to strengthen their pipelines and product portfolios while positioning themselves for potential future acquisitions.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
